SEC Form 4 · accession 0001140361-17-046612
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elaine J Heron
Director
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 8:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 14, 2017 | S | 800 | $88.895 | D | 38,385 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1All shares sold at the same price.